Becton, Dickinson and Company (BD)

Stories

BD files notice to lay off 85 workers in San Diego

Restructuring under the Excellence Unleashed program

Becton, Dickinson and Company (BD) filed a California notice on Sept. 24 that it will lay off 85 workers at its San Diego site. The notification, filed under the state's Worker Adjustment and Retraining Notification (WARN) Act, lists a Sept. 1 effective date.

Updated 2 hours ago

Embecta acquires Owen Mumford to break beyond diabetes into obesity and autoimmune drug delivery

Money Moves

Former parent company of Embecta; no remaining ownership stake

Embecta, a diabetes device company Becton Dickinson spun off in 2022, announced its first major acquisition March 19: Owen Mumford, a 74-year-old British medical device maker, for up to £150 million. The deal adds Owen Mumford's Aidaptus auto-injector platform and shifts Embecta from insulin syringes into injectable drug delivery for obesity treatments, autoimmune therapies, and emergency anaphylaxis care.

Updated May 30